98%
921
2 minutes
20
Objective: To analyze the related literature of self-reported outcomes of prostate cancer patients using bibliometric methods, and explore the research status and development trend in this field.
Methods: The literature related to self-reported outcomes of prostate cancer was searched in Web of Science core database. The literature on prostate cancer self-reported outcomes was visualized using VOSviewer, CiteSpace and R software packages.
Results: A total of 1119 relevant literatures were retrieved. Annual output consistently exceeded 100 articles since 2018, peaking at 161 in 2022. The U.S. (47.2%) and U.K. (21.5%) contributed 68.7% of publications. The University of Michigan emerged as the most productive institution. Collaborative networks showed strong U.S.-European ties, while Asian engagement intensified post-2020.The journal International Journal of Radiation Oncology Biology Physics (n=69) published most papers, whereas Journal of Clinical Oncology (n=48, citations=1,412) was most influential. Dual-map analysis revealed frequent citations from molecular/biology journals to clinical medicine literature. Barocas D.A., Cooperberg M.R., Koyama T., and Chen R.C. (21 publications each) were top producers. Ethan Basch (259 co-citations) was the most cited scholar. The EPIC scale development study (Wei et al., 2000) was the most co-cited reference. Key citation bursts included Taneja's long-term outcomes study (2013-2018) and the CHHiP radiotherapy trial (2018-2021). "Quality of life" (181 occurrences) dominated keyword analysis, followed by "radiation therapy" and "prostatectomy." Five thematic clusters emerged: radiotherapy with a blue cluster, prostatectomy with a green cluster, daily management with a red cluster, research methods with a yellow cluster and scale development with a purple cluster. Qualitative methods gained prominence after 2020, while exercise and radiotherapy remained sustained intervention focuses.
Conclusions: The reported outcomes of patients with prostate cancer have continued to receive attention in the past 10 years. In this study, three recognized bibliometric software were used for the first time to analyze the related studies on the reported outcomes of patients with prostate cancer, so as to provide reference and direction for future research.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394063 | PMC |
http://dx.doi.org/10.3389/fruro.2025.1574626 | DOI Listing |
Ann Surg Oncol
September 2025
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montreal, QC, Canada.
Urol Oncol
September 2025
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Objective: To examine differences in cancer-specific mortality (CSM) in nonmetastatic upper tract urothelial carcinoma (UTUC) patients with vs. without secondary bladder cancer (BCa) after radical nephroureterectomy (RNU).
Methods: Within the Surveillance, Epidemiology, and End Results database (SEER 2000-2021), T1-T4N0M0 UTUC patients treated with RNU and diagnosed with secondary BCa were identified.
Eur Urol Oncol
September 2025
The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:
Background And Objective: The effect of family history (FH) on prostate cancer active surveillance outcomes is unknown. Our objective is to evaluate FH of prostate, breast, ovarian, and/or pancreatic cancer in a large prospective active surveillance cohort.
Methods: Patients with recorded FH data (N = 1421) were selected.
Int J Radiat Oncol Biol Phys
October 2025
Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
Int J Radiat Oncol Biol Phys
October 2025
Division of Radiation oncology, Department of Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. Electronic address: